About ACGT
The Scientific Advisory Council is composed of 18 of the nation's preeminent physicians and researchers in gene therapy. Council members serve without remuneration and establish the scientific criteria for review of all grants, develop strict accountability guidelines, and review progress reports. Council submits recommendations for funding to the Board of Directors.
Chairman
Savio L.C. Woo, Ph.D. (bio)Professor and Chair of Gene and Cell Medicine
Mt. Sinai School of Medicine
New York, New York
Council Members
Stuart A. Aaronson, M.D. (bio)Jack and Jane B. Aron Professor of Neoplastic Diseases Chairman,
Department of Oncological Sciences.
Mount Sinai School of Medicine
New York, New York
Xandra O. Breakefield, Ph.D. (bio)
Professor of Neurology, Harvard
Medical School; Geneticist, Center
for Molecular Imaging Research
Massachusetts General Hospital
Boston, MA
Lieping Chen M.D., Ph.D. (bio)
Professor of Dermatology and Oncology
Director of Dermatology Research
Johns Hopkins University School of Medicine
Baltimore, Maryland
Stephen L. Eck, M.D., Ph.D. (bio)
Vice President
Translational Medicine & Pharmacogenics
Eli Lilly and Company
Indianapolis, IN
Joseph C. Glorioso III, Ph.D. (bio)
Chairman and Professor of the Department of Molecular Genetics
and Biochemistry
University of Pittsburgh School of Medicine
Pittsburgh, PA
Carl H. June, M.D (bio)
Director, Translational Research and Professor,
Department of Pathology and Laboratory Medicine,
University of Pennsylvania
Philadelphia, PA
Wen-Hwa Lee, Ph.D. (bio)
Donald Bren Professor and Chair
Department of Biological chemistry,
University of California, Irvine, California
Michael T. Lotze, M.D. (bio)
Vice Chair for Research and Chief,
Division of Translational Research,
Department of Surgery Professor of Surgery and Bioengineering,
Asst. Vice Chancellor for Interdisciplinary Research and Training,
University of Pittsburgh Schools of Health Science
Assoc. Director, Strategic Partnerships,
University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania
Robert L. Martuza, M.D., F.A.C.S. (bio)
Chief of Neurological Services
Massachusetts General Hospital
Professor of Neurosurgery Harvard Medical School
Boston, Massachusetts
A. Dusty Miller, Ph.D. (bio)
Member of the Divisions of Human Biology and Basic Sciences,
Fred Hutchinson Cancer Research Center,
Affiliate Professor of Pathology,
University of Washington
Seattle, WA
Drew M. Pardoll, M.D., Ph.D. (bio)
Professor of Medicine, Oncology, Pathology and Molecular Biology and Genetics
Co-Director, Division of Immunology/Hematopoiesis
Sidney Kimmel Cancer Center
Johns Hopkins University School of Medicine
Baltimore, Maryland
Jack A. Roth, M.D., F.A.C.S. (bio)
The University of Texas MD Anderson Cancer Center
Professor and Chairman, Bud Johnson Clinical Distinguished Chair
Department of Thoracic & Cardiovascular Surgery
Professor of Molecular & Cellular Oncology
Director, W.M. Keck Center for Innovative Cancer Therapies
Chief, Section of Thoracic Molecular Oncology
Houston, Texas
Erkki Ruoslahti, M.D., Ph.D. (bio)
Distinguished Professor
The Burnham Institute Adjunct Professor of Bioengineering,
University of California at San Diego
La Jolla, California
Stephen J. Russell, M.D., Ph.D. (bio)
Director, Molecular Medicine and Professor of Medicine, Mayo Clinic,
Rochester, MN
Thomas J. Wickham, Ph.D. (bio)
Director Non-Clinical Development
EMD Lexigen
Billerica, Massachusetts
George D. Yancopoulos, M.D., Ph.D. (bio)
President, Regeneron Laboratories & Chief Scientific Officer,
Regeneron Pharmaceuticals, Inc.
Judah Folkman, M.D. (In Memoriam) (bio)
Director of The Vascular Biology Program, Children's Hospital;
Andrus Professor of Pediatric Surgery and Professor of Cell Biology;
Harvard Medical School and Children's Hospital, Boston, Massachusetts
©2007 Alliance for Cancer Gene Therapy 96 Cummings Point Road, Stamford, CT, 06902